India’s first Covid-19 vaccine by Bharat Biotech to enter trials
India-based biotechnology company Bharat Biotech has secured regulatory approval from the Drug Controller General of...
Read More...
Focus:
India
-
![Ulinastatin]()
Bharat Serums to assess sepsis drug Ulinastatin for Covid-19
India-based Bharat Serums and Vaccines (BSVL) has secured regulatory approval to assess sepsis drug, Ulinastatin,...
Read More...
-
![]()
Indian Health Ministry issues draft rules for new Covid-19 drugs
The Indian Health Ministry has issued a draft notification for ‘compassionate use’ of any unapproved...
Read More...
-
![Nafamostat; Sun Pharma; Covid]()
Sun Pharma trials plant-derived drug to treat Covid-19
India-based Sun Pharmaceutical Industries has launched a Phase II clinical trial of plant-derived (phytopharmaceutical) drug...
Read More...
-
![Nafamostat; Sun Pharma; Covid]()
Sun Pharma to trial Nafamostat for Covid-19 treatment
Sun Pharmaceutical Industries has secured approval from the Drugs Controller General of India (DCGI) to...
Read More...
-
![Favipiravir trial]()
Glenmark starts Phase III Favipiravir combination study for Covid-19
Glenmark Pharmaceuticals has launched a Phase III clinical trial to assess Favipiravir in combination with...
Read More...
-
![Covid]()
Strides Pharma gets regulatory nod to trial Favipiravir in India
Strides Pharma Science has obtained approval from the Drug Controller General of India (DCGI) to...
Read More...
-
![Favipiravir]()
Glenmark begins Phase III trials of favipiravir for Covid-19 in India
India-based Glenmark Pharmaceuticals has started Phase III clinical trials of anti-flu drug favipiravir as a...
Read More...
-
![Favipiravir]()
Glenmark gets approval to trial favipiravir for Covid-19 in India
Glenmark Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) to evaluate...
Read More...
-
![Coronavirus in India]()
Coronavirus in India: how the COVID-19 could impact the fast-growing economy
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in...
Read More...
